Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Compliance Officers: Establish Credibility with Consistent, Well-Documented Decisionmaking
From - G2 Compliance Advisor
One of the tougher issues a non-lawyer compliance officer faces is a challenge to their decisions and recommendations by other members of…
Singulex Assay Could ID Declining Cardiac Health
From - Laboratory Industry Report
An assay developed by a California-based laboratory that determines the levels of troponin could be used as a…
Studies Examine Impact of Federal and State Policies on Health Costs and Utilization
From - National Intelligence Report
Lab leaders often read about national and state policies. But effects of them may be harder to discover. The Health Care Cost Institute (HCCI) was motivated to…
LabCorp Continues Shopping Spree by Acquiring ClearPath Diagnostics
...
Register
PAMA Update: Status Report on Implementation of New Medicare Fee Schedule for Part B Lab Tests
...
Register
OIG Report: Total Medicare Lab Test Payments in 2015 Same as in 2014
...
Register
Theranos Closes Labs to Focus on Technology
...
Register
Randox Labs Introduces Alzheimer’s Genetic Test
...
Register
OIG Addresses Status of PAMA Implementation
From - Laboratory Industry Report
Changes to Medicare Part B payment for lab tests mandated by the Protecting Access to Medicare Act of 2014 (PAMA) take effect on…
OIG Celebrates 40 Years of Fraud Fighting
From - National Intelligence Report
Oct. 15, 2016 marks 40 years since the U.S. Department of Health & Human Services (HHS) Office of Inspector General (OIG) was launched in…